SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 87 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,990 | -25.5% | 24,059 | 0.0% | 0.01% | -23.5% |
| Q2 2023 | $60,388 | +145.4% | 24,059 | +71.1% | 0.02% | +112.5% |
| Q1 2023 | $24,603 | +44.7% | 14,059 | 0.0% | 0.01% | +14.3% |
| Q3 2022 | $17,000 | +21.4% | 14,059 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $14,000 | -83.1% | 14,059 | 0.0% | 0.01% | -81.5% |
| Q1 2021 | $83,000 | – | 14,059 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |